Showing results (71-80 of 3,415) with videos related to
Sort By:
Pageof 342
AJNR. American Journal of Neuroradiology|October 22, 2016
Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization OutcomesT A Tomsick, J Carrozzella, L Foster, et al.Stroke|April 5, 2014
Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experienceSharon D Yeatts, Renee H Martin, Christopher S Coffey, et al.International Journal of Cancer|June 19, 2001
Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panelM Mitas, K Mikhitarian, C Walters, et al.International Journal of Stroke : Official Journal of the International Stroke Society|January 5, 2022
J-shape relation of blood pressure reduction and outcome in acute intracerebral hemorrhage: A pooled analysis of INTERACT2 and ATACH-II individual participant dataXia Wang, Gian Luca Di Tanna, Tom J Moullaali, et al.Stroke|July 7, 2020
Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2Mayumi Fukuda-Doi, Haruko Yamamoto, Masatoshi Koga, et al.The Lancet. Neurology|March 23, 2019
Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trialMagdy Selim, Lydia D Foster, Claudia S Moy, et al.Neurocritical Care|April 24, 2013
Increased brain volume among good grade patients with intracerebral hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) studyAdnan I Qureshi, Shahram Majidi, Waqas I Gilani, et al.Neurocritical Care|May 17, 2011
Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhageAdnan I Qureshi, Yuko Y Palesch, Renee Martin, et al.Stroke|December 24, 2015
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke AssociationBart M Demaerschalk, Dawn O Kleindorfer, Opeolu M Adeoye, et al.Clinical Pharmacology and Therapeutics|January 29, 2017
Clinical Considerations for Oncolytic Viral Therapies: A Regulatory PerspectiveK LiuPageof 342